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Abstract
Background: Understanding nosocomial pathogen transmission is restricted by culture limitations. Novel platforms,
such as PCR-based electron spray ionization-time-of-flight-mass spectrometry (ESI-TOF-MS), may be useful as
investigational tools.
Methods: Traditional clinical microbiology (TCM) and PCR/ESI-TOF-MS were used to recover and detect
microorganisms from the hands and personal protective equipment of 10 burn intensive care unit (ICU) healthcare
workers providing clinical care at a tertiary care military referral hospital. High-use environmental surfaces were
assessed in 9 burn ICU and 10 orthopedic patient rooms. Clinical cultures during the study period were reviewed
for pathogen comparison with investigational molecular diagnostic methods.
Results: From 158 samples, 142 organisms were identified by TCM and 718 by PCR/ESI-TOF-MS. The molecular
diagnostic method detected more organisms (4.5 ± 2.1 vs. 0.9 ± 0.8, p < 0.01) from 99% vs. 67% of samples (p < 0.01).
TCM detected S. aureus in 13 samples vs. 21 by PCR/ESI-TOF-MS. Gram-negative organisms were less commonly
identified than gram-positive by both methods; especially by TCM. Among all detected bacterial species, similar
percentages were typical nosocomial pathogens (18-19%) for TCM vs. PCR/ESI-TOF-MS. PCR/ESI-TOF-MS also
detected mecA in 112 samples, vanA in 13, and KPC-3 in 2. MecA was associated (p < 0.01) with codetection of
coagulase negative staphylococci but not S. aureus. No vanA was codetected with enterococci; one KPC-3 was
detected without Klebsiella spp.
Conclusions: In this pilot study, PCR/ESI-TOF-MS detected more organisms, especially gram-negatives, compared to
TCM, but the current assay format is limited by the number of antibiotic resistance determinants it covers. Further
large-scale assessments of PCR/ESI-TOF-MS for hospital surveillance are warranted.
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Background
Healthcare-associated infections (HAI) account for sub-
stantial morbidity and mortality worldwide [1]. These
occur both in epidemics, with a common pathogen, and
in endemic settings, where no clusters or common
pathogens are identified. Numerous reservoirs for epide-
miologically significant organisms have been demon-
strated in healthcare settings. These include high-use
environmental surfaces, such as door handles and hand-
rails; patient care items such as bedside tables, bedrails,
and intravenous fluid (IV) pumps; healthcare provider
protective clothing such as lead aprons; and plumbing
structures including drains and faucet heads, and com-
puter equipment, among many others [2-7]. Contamin-
ation of personal protective equipment (PPE) during
patient care is a mechanism for transient colonization in
healthcare workers (HCW) after doffing PPE [8,9]. How-
ever, in any healthcare environment, identification of a
reservoir for endemic transmission of pathogens is the
exception rather than the rule. Identifying reservoirs is
limited by the sensitivity of traditional clinical microbiol-
ogy (TCM), especially since many pathogens establish
biofilms, which are recalcitrant to TCM, on environ-
mental surfaces [10,11]. More accurate identification
and speciation of environmental pathogens should assist
infection prevention efforts and mitigate excess patient
morbidity and mortality.
Molecular techniques are increasingly used for mi-
crobial detection; however, these methods often focus
on a single pathogen, such as methicillin-resistant
Staphylococcus aureus (MRSA), or are used only after
initial growth of bacteria in culture [12,13]. Ideal mo-
lecular methods would include the ability to screen
samples for numerous species rapidly and simultan-
eously. The Ibis T5000 (PCR electron spray ionization-
time-of-flight-mass spectrometry; PCR/ESI-TOF-MS)
technology is based on the determination of the ratios
of the four nucleotide bases (A, T, G and C) in multiple
(n = 16) PCR amplicons that target conserved bacterial
genes (including the 16S rDNA gene). Using a triangu-
lation algorithm based on multiple independent ampli-
con mass determinations, it can identify and speciate
all eubacterial species present in a complex sample that
are present at greater than 3% of the microbial burden
[14]. The technology has been recently reviewed in
detail [15-17]. It has been used in outbreak investiga-
tions of Streptococcus pyogenes and Acinetobacter spp.,
to characterize and genotype a diverse collection of
S. aureus isolates, and to characterize orthopedic infec-
tions [18-23]. However, no previous study using this
technology has evaluated recovery of endemic patho-
gens in a healthcare environment. This pilot study uses
TCM and PCR/ESI-TOF-MS to compare contamin-
ation of HCW hands and PPE used in the care of
patients on the burn intensive care unit (ICU), and con-
tamination of high-use surfaces in the burn ICU and the
orthopedic ward. Additionally, we explored whether
results obtained from either TCM or PCR/ESI-TOF-MS
reflected contemporaneous clinical cultures obtained from
hospitalized patients on the study units.
Methods
Isolates tested
Sample acquisition was planned from 20 occupied
single-bed patient care rooms, ten from the burn ICU
(burn unit rooms were designed with anterooms and
universal gowns and gloves are used) and ten from the
orthopedic ward. Nine rooms in the burn ICU had sam-
ple acquisition completed due to patient census. In the
burn ICU, one HCW for each selected patient room
was also enrolled for screening. Two HCW completed
patient care in the same room in one instance due to
patient census. Two swabs (one for TCM and one for
PCR/ESI-TOF-MS; Fisherfinest Transport Swabs with
Liquid Stuarts) were obtained using a standard rolling
technique from: the door handle exiting the room, sink
faucet, bedrail, IV pump, in-room computer keyboard,
and in-room computer mouse where available. In rooms
where any of these items was unavailable, these data
were omitted. Bandage shears from 10 orthopedic sur-
geons were also swabbed.
HCW screening
Two swabs (Fisherfinest Transport Swabs with Liquid
Stuarts) were obtained (using the standard rolling
technique) from subjects’ hands. HCW donned PPE
(gowns and gloves) and managed their patients in sin-
gle patient room. Upon return, the surfaces of gloves,
the waistline of the gown, and the hands after glove re-
moval and before hand hygiene were swabbed. One
swab was tested using TCM techniques and the other
by PCR/ESI-TOF-MS.
Clinical culture data
A summary of de-identified clinical culture and Clostridium
difficile toxin assay results (included due to its signifi-
cance as a HAI bacterial pathogen, inability to isolate by
routine clinical culture, and in order to correlate against
any PCR/ESI-MS-TOF C. difficile results obtained)
obtained during routine patient care from the burn ICU
and orthopedics ward during the study period was
retrospectively collated via the patient’s electronic med-
ical records. Clinical cultures (and C. difficile toxin
assay results) were included if performed from t-14
through t + 14 days with respect to the dates of room
sampling for that unit, which took place from May-July
2010. No concurrent chart review was performed for
hospital length of stay, definitions of infections, or any
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other clinical criteria since the hospital microbial ecology
was the outcome of interest, and no potentially duplicate
isolates from the same patient were excluded. Organisms
were considered potentially clinically relevant if isolated
on at least five occasions from separate clinical cultures
during the study period and they were not common skin
contaminants. For the purposes of statistical comparisons,
coagulase negative staphylococci (CNS) were excluded,
and aerobic gram-negative rods other than Escherichia
coli, Acinetobacter spp., Klebsiella spp., Pseudomonas spp.,
or Enterobacter spp. were coalesced into one category.
PCR/ESI-TOF-MS
Methods for genotypic characterization of bacterial and
fungal isolates, and genetic resistance elements (mecA,
vanA, and KPC-3) using the commercially available Ibis
T5000 (Ibis Biosciences) have been described elsewhere
[21,24]. Swabs were frozen at −80°C and shipped on dry
ice for batched PCR/ESI-TOF-MS testing. Following
thawing of the swabs they were placed into sterile micro-
centrifuge tubes containing 270 μl of ATL Lysis buffer
(Qiagen, Germantown, MD, cat# 19076) and 30 μl pro-
teinase K (Qiagen, cat# 19131). Samples were incubated at
56°C for one hour. One hundred μl of a mixture contain-
ing 50 μl each of 0.1 mm and 0.7 mm Zirconia beads
(Biospec cat# 11079101z, 11079107zx respectively) were
added to the samples which were then homogenized for
10 min at 25 Hz using a Qiagen Tissuelyser. Nucleic acid
from the lysed sample was then extracted using the
Qiagen DNeasy kit (Qiagen cat# 69506). 10 μl of each
sample was loaded per well onto the BAC detection PCR
plate (Abbott Molecular, cat# PN 05 N13-01). The BAC
detection plate is a 96 well plate which contains 16 pri-
mers that survey all bacterial organisms by using multiple
omnipresent loci (e.g. 16S rDNA sequences) and multiple
pluripresent loci (e.g. the tufB gene). This has been vali-
dated against 613 organisms, meaning it correctly identi-
fied them when presented with unknowns. The system
also detects the presence of several key antibiotic resist-
ance markers: vanA and vanB (vancomycin resistance) in
Enterococcus spp., KPC-3 (carbapenem resistance) in
gram-negative bacteria, and mecA (methicillin resistance)
in Staphylococcus spp. An internal calibrant of synthetic
nucleic acid template is also included in each assay, con-
trolling for false negatives (e.g. from PCR inhibitors) and
enabling a semi-quantitative analysis of the amount of
template DNA present. PCR amplification was carried out
as per Ecker et al [25]. The PCR products were then
desalted in a 96-well plate format and sequentially electro-
sprayed into a time-of-flight mass spectrometer. The spec-
tral signals were processed to determine the masses of each
of the PCR products present with sufficient accuracy that
the base composition of each amplicon could be unambigu-
ously deduced. Using combined base compositions from
multiple PCRs, the identities of the pathogens and a semi-
quantitative determination of their relative concentrations
in the starting sample were established by using a propri-
etary algorithm to interface with the Ibis database of known
organisms.
Semi-quantitative data was obtained from all PCR/
ESI-TOF-MS analyses as each well of each assay is
seeded with a DNA template that contains the appro-
priate primer binding sites for the primers in that well.
These primer binding sites flank a synthetic DNA
sequence of known composition. By comparing the
amount of each species’ amplimer produced in a well to
the amount of the amplimer resulting from the synthetic
template the number of genomes/well of each bacterial
species can be approximated. However, given the ex-
ploratory nature of the study, semi-quantitative data
were not analyzed here.
TCM
Clinical microbiology swabs were transferred to brain
heart infusion (BHI) broth medium and this was
incubated 48 h at 35–37°C. If the BHI demonstrated
turbidity, the inoculated broth was subcultured onto
sheep’s blood agar plates (BBL, Cockeysville, MD, USA)
and MacConkey agar plates (BBL, Cockeysville, MD,
USA). All colony forming units were worked up with no
minimum threshold for evaluation. Organisms and
antimicrobial resistance testing were performed using
standard clinical microbiology techniques including
semi-automated mechanisms for gram-negative isolates
(Siemens WalkAway 40 System; Siemens Healthcare
Diagnostics, Deerfield, IN, USA).
Human subject protection
The protocol was reviewed and approved by the Brooke
Army Medical Center Institutional Review Board and
human subjects provided informed consent.
Statistical analysis
Descriptive statistics were used to summarize findings.
Analysis was performed using existing software (SPSS,
version 19.0; IBM SPSS). Categorical variables were
compared by chi-squared test, and t-test for normal con-
tinuous variables. Paired tests were applied when com-
paring two methods of testing from the same sample;
McNemar’s test was used for nonparametric paired
testing. Means and standard deviations are expressed
throughout as mean ± SD. All p-values are two-tailed
and statistical significance represented by p < 0.05.
Results
Samples were taken from 158 sites; 40 from HCW (10
pre-patient care hands, 10 gloves, 10 gowns, 10 post-
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patient care hands), 19 from door handles, sink faucets,
IV pumps and bedrails, 17 from keyboards, 15 from
computer mice, and 10 from orthopedic shears. From
these sites, 142 organisms were recovered by TCM and
718 by PCR/ESI-TOF-MS. At all sites, compared to
TCM, PCR/ESI-TOF-MS recovered a larger number of
organisms (4.5 ± 2.1 vs. 0.9 ±0.8, p <0.01) from a greater
proportion of samples (99% vs. 67%, p <0.01; Table 1).
HCW hands revealed more organisms by PCR/ESI-
TOF-MS than TCM before care (3.9 ± 2.0 vs. 0.4 ± 0.5,
p < 0.01) and after care (3.8 ±1.6 vs. 0.6 ± 0.5, p < 0.01).
PCR/ESI-TOF-MS also recovered a greater number of
organisms than TCM among used gowns (2.8 ± 1.1 vs.
0.6 ± 0.7, p < 0.01), but not gloves (3.1 ± 2.3 vs. 1.3 ± 1.6,
p = 0.10).
Organisms recovered from 393 clinical cultures
included S. aureus, Klebsiella pneumoniae, Enterobacter
spp., Streptococcus spp. (68% viridans group), Pseudomonas
aeruginosa, and Acinetobacter baumannii-calcoaceticus
complex; the proportions of these organisms detected by
PCR/ESI-TOF-MS and TCM are depicted in Figure 1.
The most common clinical culture sources included
respiratory (29%), wound (22%), body fluid (19%), and
blood (16%). There were no positive toxin assay results
for C. difficile. Twelve isolates of CNS were recovered,
8 from blood cultures. By the study definition of po-
tentially clinically relevant organisms, and combining
less commonly recovered aerobic gram-negative rods
(e.g. Serratia, Morganella, Stenotrophomonas spp.), 84%
of clinical cultures were potentially clinically relevant.
There was no difference in the proportion of potentially
clinically relevant organisms detected by TCM vs. PCR/
ESI-TOF-MS (18 vs. 19%, p = 0.77). Including strepto-
cocci, which were the third most commonly recovered
organisms among clinical cultures, 19% of TCM organ-
isms recovered were of potential clinical significance vs.
31% for PCR/ESI-TOF-MS (p < 0.01). Comparison of
samples positive for a potentially clinically relevant or-
ganism revealed consistently higher proportions detected
by PCR/ESI-TOF-MS (Table 2). This was statistically sig-
nificant by McNemar’s test with or without inclusion of
streptococci, and remained significant even when com-
paring only samples positive for the most commonly cul-
tured bacteria (S. aureus, K. pneumoniae, Enterobacter
spp., Pseudomonas spp., Acinetobacter spp., and E. coli).
Distribution of potentially clinically relevant organ-
isms, plus CNS, recovered from HCW hands/PPE, and
the hospital environment, are presented in Tables 3 and
4 respectively. Most organisms recovered by either
mechanism were gram-positive. Eight-six total CNS iso-
lates were recovered by TCM and 214 by PCR/ESI-TOF-
MS; 13 S. aureus by TCM and 21 by PCR/ESI-TOF-MS.
Gram-negative organisms were less commonly identi-
fied, especially by TCM. There were 3 Acinetobacter spp.
recovered by TCM and 15 by PCR/ESI-TOF-MS; 4
Enterobacter spp. by TCM and 7 by PCR/ESI-TOF-MS;
no E. coli by TCM and 6 by PCR/ESI-TOF-MS, no
Klebsiella spp. by TCM and 21 by PCR/ESI-TOF-MS, no
Pseudomonas spp. by TCM and 9 by PCR/ESI-TOF-MS.
These five gram-negative rod species (GNR) contributed
177 of 389 (45%) clinical cultures during the study
period, however only 7 (5%) of the environmental sam-
ples were positive for these organisms by TCM, and 58
(8%) by PCR/ESI-TOF-MS. TCM contributed to only
Table 1 PCR/Electron spray ionization-time-of-flight-mass spectrometry (PCR/ESI-TOF-MS) versus traditional clinical
microbiology (TCM) for detection of organisms contaminating high-use surfaces, healthcare worker hands, and
personal protective equipment in a burn intensive care unit (ICU) and an orthopedic ward
Burn ICU # sites with at least one organism
recovered (# organisms recovered)
Orthopedic ward # sites with at least one organism
recovered (# organisms recovered)
Screened PCR/ESI-TOF-MS TCM Screened PCR/ESI-TOF-MS TCM
Bedrails 9 9 (44) 7 (11) 10 10 (53) 8 (11)
Door handles 9 9 (34) 6 (7) 10 10 (48) 3 (3)
Sink faucets 9 9 (41) 7 (8) 10 10 (56) 9 (11)
IV pumps 9 8 (34) 6 (7) 10 10 (53) 5 (6)
Keyboards 9 9 (48) 9 (16) 8 8 (50) 8 (11)
Mouse 9 9 (38) 6 (8) 6 6 (35) 4 (6)
Shears 10 10 (48) 7 (8)
Hands pre-care 10 10 (39) 4 (4)
Gloves 10 10 (31) 6 (13)
Gowns 10 9 (28) 5 (6)
Hands post-care 10 10 (38) 6 (6)
Total 94 92 (375) 62 (86) 64 64 (343) 44 (56)
Total number of isolates recovered.
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11% of total detections of these GNR, vs. 38% of all
S. aureus detections, a difference that was statistically
significant (p <0.01).
In addition to detection of bacteria, PCR/ESI-TOF-MS
detected the mecA gene in 112 samples. The majority of
these codetected CNS with no S. aureus present (93;
83%). The remainder were comprised of S. aureus alone
(9); S. aureus and CNS together (8), or no staphylococci
(2). MecA detection was statistically associated with
CNS codetection (p <0.01) but not with either S. aureus
detection or MRSA growth on culture (p = 0.22) from
the same samples. Of 13 S. aureus isolates recovered by
TCM, 9 were MRSA. Seven of 9 MRSA cultured also
had mecA and S. aureus detected by PCR/ESI-TOF-MS
from the same sample (one detected mecA with no
S. aureus and the other detected neither). Of the two
samples for which mecA but no staphylococci were
recovered, one grew Acinetobacter spp. and enterococci
Figure 1 Number of pathogens of potential clinical relevance detected by clinical culture versus numbers detected on healthcare
worker hands, personal protective equipment and environmental surfaces by traditional clinical microbiology (TCM) and PCR/Electron
spray ionization-time-of-flight-mass spectrometry (PCR/ESI-TOF-MS) in the burn unit and orthopedic ward. “Aerobic gram-negative rods:”
Clinical culture: 1 Achromobacter xylosoxidans, 1 Aeromonas sobria, 4 Citrobacter koseri, 4 Morganella morganii, 5 Providencia rettgeri, 2 Serratia
marcescens, 8 Stenotrophomonas maltophilia. PCR/ESI-TOF-MS: 1 Actinobacillus sp., 1 Azoarcus sp., 4 Bordetella avium, 1 Bordetella bronchiseptica, 1
Bordetella parapertussis, 2 Bordetella petri, 2 Burkholderia cenocepacia, 4 Burkholderia thailandensis, 1 Campylobacter sp., 1 Caulobacter sp., 1
Leptothrix cholodnii, 1 Nitrosomonas europaea, 2 Novosphingobium aromaticivorans, 1 Raoultella ornithinolytica, 3 S. marcescens, 1. S. flexneri, 1
Sphingomonas sp., 1 Vibrio rumoiensis, 1 Vibrio vulnificus, 1 Xanthomonas oryza.
Table 2 PCR/Electron spray ionization-time-of-flight-mass spectrometry (PCR/ESI-TOF-MS) versus traditional clinical
microbiology (TCM) for detection of pathogens of potential clinical relevance on healthcare worker hands/personal
protective equipment and high-use surfaces (n = 158)
PCR/ESI-TOF-MS # sites with
at least one organism
recovered (%)
TCM # sites with





Including streptococci 123 (77.8) 20 (12.7) <0.01
Not including streptococci 94 (59.4) 19 (12.8) <0.01
Six most common bacteria
recovered from clinical cultures**
58 (36.7%) 16 (10.1) <0.01
*S. aureus, K. pneumoniae, Enterobacter spp., Pseudomonas spp., Acinetobacter spp., Aerobic gram-negative rods (see Figure 1), Candida spp., E. coli, Enterococcus
spp., and Haemophilus influenzae.
**S. aureus, K. pneumoniae, Enterobacter spp., Pseudomonas spp., Acinetobacter spp., and E. coli.
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by TCM. PCR/ESI-TOF-MS detected A. baumannii,
Candida albicans, and Polynucleobacter spp. The other
sample was TCM negative with both P. acnes and
Streptococcus thermophilus detected by PCR/ESI-TOF-MS.
There were 13 samples in which vanA was detected. None
of these had enterococci codetected by PCR/ESI-TOF-MS,
and no cultures grew vancomycin-resistant enterococci
(VRE); one grew susceptible enterococci. There was a signifi-
cant association with lactobacilli codetection; 6 of 20 lacto-
bacillus detections had vanA codetected (p<0.01). However,
7 samples were positive for vanA with neither lactobacilli
nor enterococci codetections. There were no clear trends
among the other organisms codetected with vanA, but 12 of
13 vanA samples also had a mecA codetected.
KPC-3 was detected in 2 samples, in one of which K.
pneumoniae was codetected (along with Clostridium per-
fringens, Saccharomyces cerevisiae, S. thermophilus, CNS,
and mecA). The other KPC-3 positive sample codetected
CNS, Streptococcus agalactiae, Propionibacterium acnes,
Lactobacillus salivarius, Nocardia asteroides, Bordetella
bronchiseptica, and vanA.
There were a number of rare or unexpected microor-
ganisms detected in the hospital environment by PCR/
ESI-TOF-MS, including Shigella, Vibrio and Bartonella
spp. Selected unusual or less commonly detected organ-
isms are presented in Table 5.
Few clinically relevant pathogens were detected by
TCM and not by PCR/ESI-TOF-MS. Altogether, PCR/
ESI-TOF-MS failed to detect 35 of the 142 isolates from
TCM, most of which were identified as Micrococcus spp.
and CNS. There were five Enterococcus spp. isolated by
TCM which went undetected by PCR/ESI-TOF-MS; add-
itional clinically relevant organisms included S. aureus
(2), Enterobacter spp. (2), and Acinetobacter spp. (1).
Discussion
Endemic transmission of nosocomial pathogens, especially
gram-negative organisms, in a hospital environment is
often poorly defined and difficult to control. While some
studies have demonstrated that previous occupancy of an
ICU room by a patient with multidrug-resistant (MDR)
gram-negative bacteria is a risk factor for acquisition by
subsequent occupants, others have infrequently recovered
gram-negatives from the hospital environment [26,27].
Additionally, while contact precautions have been
demonstrated to have efficacy in control of transmission
of MRSA, VRE and C. difficile, the evidence is less robust
for gram-negative organisms [28,29]. Although gram-
negatives are the predominant pathogens in cases of
ventilator-associated pneumonia and in ICU HAIs, where
death from HAI is most likely to occur, existing guidelines
pertaining to control of MDR pathogens either exclude
gram-negatives or acknowledge limitations in recommen-
dations pertaining to these organisms [30-32]. Increased
ability to detect environmental reservoirs of these organ-
isms should lead to improvements in targeted control
efforts. Prior studies have evaluated (by TCM) the fre-
quency of microorganisms on high-use surfaces, HCW,
PPE, and other items in the healthcare environment, with
widely differing results depending on the site sampled and
organism of interest. Many have focused on one organism
in the immediate surroundings of a patient known to be
colonized with that organism [3,9,26,33-35]. Apart from
this context, studies in non-outbreak settings often evalu-
ate epidemiologically significant pathogens for one site of
interest per study. One evaluation of MDR A. baumannii
contamination in a medical intensive care unit found none
except in colonized patients’ immediate surroundings [5].
In our institution, an evaluation (by TCM) was made of
Table 3 PCR/Electron spray ionization-time-of-flight-mass spectrometry (PCR/ESI-TOF-MS) versus traditional clinical
microbiology (TCM) for detection of most frequently recovered potentially clinically relevant pathogens, plus
coagulase negative staphylococci (CNS), contaminating healthcare workers and personal protective equipment
PCR/ESI-TOF-MS (n= 77) TCM (n= 23)
Organism Hands pre-care Gloves Gowns Hands post-care Hands pre-care Gloves Gowns Hands post -care
CNS 12 6 8 12 4 4 3 3
Staphylococcus aureus 3 3 1 3 1 1
Streptococci* 9 4 3 1 1
Acinetobacter spp.** 3 1 1
Enterobacter spp.*** 1 2
Escherichia coli 1 1
Klebsiella pneumoniae 1 3 1 1
Pseudomonas spp.**** 1 1
Candida spp.***** 2
*TCM: 1 Group D Streptococcus; PCR/ESI-TOF-MS: 7 S. agalactiae, 10 viridans group streptococci.
**TCM: 1 A. baumannii; PCR/EIS-MS: 2 A. baumannii, 2 A. calcoaceticus.
***TCM: 2 Enterobacter aerogenes; PCR/ESI-TOF-MS: 1 E. aerogenes.
****PCR/ESI-TOF-MS: 1 Pseudomonas fluorescens, 1 Pseudomonas mendocina.
*****PCR/ESI-TOF-MS: 1 C. albicans, 1 Candida glabrata.
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Table 4 PCR/Electron spray ionization-time-of-flight-mass spectrometry (PCR/ESI-TOF-MS) versus traditional clinical microbiology (TCM) for detection of most
frequently recovered potentially clinically relevant organisms, plus coagulase negative staphylococci (CNS), contaminating high-use surfaces
Bacteria PCR/ESI-TOF-MS (# isolates) n = 305 TCM (# isolates) n = 89
Bedrail Door handle Faucet IV pump Keyboard Mouse Shears Bedrail Door handle Faucet IV pump Keyboard Mouse Shears
CNS 24 31 28 23 30 22 19 11 6 14 9 16 9 7
Enterococci* 2 1 2 1 1
S. aureus 4 1 4 2 3 3 1 1 1 2
Streptococci** 7 8 12 12 17 7 5 1
Acinetobacter spp.*** 2 1 2 6 1 1
Enterobacter spp.**** 3 1 1 1 1 1
E. coli 2 1 1
K. pneumoniae 7 1 3 1 3
Pseudomonas spp.***** 4 2 1
Candida spp.****** 7 3 5 3 1 2
*TCM: “Enterococcus spp.”; PCR/ESI-TOF-MS: 2 Enterococcus faecalis, 1 Enterococcus faecium.
**TCM: 1 viridans group streptococci; PCR/ESI-TOF-MS: 1 Group D Streptococcus, 24 S. agalactiae, 8 Streptococcus pneumoniae, 1 S. pyogenes, 1 “Streptococcus spp.”, 33 viridans group streptococci.
***TCM: 2 A. baumannii; PCR/ESI-TOF-MS: 10 A. baumannii, 1 “Acinetobacter spp.”
****TCM: 2 Enterobacter cloacae; PCR/ESI-TOF-MS: 4 E. cloacae; 2 Enterobacter sakazakii.
*****PCR/ESI-TOF-MS: 1 P. aeruginosa, 2 Pseudomonas entomophila/putida, 3 P. fluorescens, 1 “Pseudomonas spp.”



















protective lead garments at various sites, with only 5 of
182 samples positive for any bacteria, all normal skin flora;
another assessment of computer keyboards/mice recov-
ered S. aureus, Acinetobacter spp., or Pseudomonas spp.
on 17% of tested surfaces [2,4]. One study demonstrated
a majority of bedside charts in the ICU were con-
taminated with MDR bacteria [36].
Against this backdrop, we sought to determine the
burden and spectrum of microorganisms detected from
HCW, PPE, and a variety of high-use hospital environ-
mental surfaces by PCR/ESI-TOF-MS compared to
TCM, and to compare the two methodologies in
reference to the most commonly identified microorgan-
isms detected among clinical cultures. This study is the
first to our knowledge to evaluate selected sections of
the hospital microbiome, comparing TCM and the un-
biased T-5000-based PCR/ESI-TOF-MS method, in an
effort to understand potential reservoirs of endemic
nosocomial bacteria. Compared to traditional culture,
PCR/ESI-TOF-MS detected more microbes, including
more pathogens of potential clinical relevance, from a
greater number of surfaces, hands of HCW, and PPE.
PCR/ESI-TOF-MS also disproportionately recovered
more gram-negative organisms missed by culture than S.
Table 5 Selected rare organisms detected by PCR/Electron spray ionization-time-of-flight-mass spectrometry
(ESI-TOF-MS) in the hospital environment
Microbiology # PCR/ESI-TOF-MS detections
HCW/PPE Burn ICU rooms Orthopedic rooms/Shears
Gram-positive
Cocci
Leuconostoc spp. 2 0 5
S. pyogenes 1
S. pneumoniae 1 7
Bacilli
Clostridium spp. 1 1 2
Clostridium tetani 1 1
Listeria monocytogenes 2
Nocardia spp. 3 1 6
Gram-negative
Cocci
Neisseria spp. 1 2
Aerobic Bacilli
Bordetella spp. 3 1 4
Burkholderia spp. 1 2 3
Polynucleobacter spp. 7 11 7
Shigella flexneri 1
Vibrio spp. 1 1
Anaerobic Bacilli







Alternaria 2 1 4
Saccharomyces cerevisiae 1 3 17
Other fungi* 1 3
HCW healthcare worker, PPE personal protective equipment, ICU intensive care unit.
* One of each: Botryosphaeria rhodina, Macroventuria spp., Cochliobolus spp., Arthrographis cuboidea.
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aureus. As would be expected, both TCM and PCR/ESI-
TOF-MS also detected many clinically less important
organisms. Potentially clinically relevant pathogens
accounted for similar proportions of all results (an esti-
mated “signal-to-noise” ratio), unless streptococci, which
are not typically considered major HAI pathogens, were
included. However, compared to TCM, PCR/ESI-TOF-
MS was able to detect potentially clinically relevant
pathogens from 3-6x the number of sites screened, de-
pending upon the inclusivity of the definition of “clinic-
ally relevant”. There is no standard definition for
potential clinical relevance, and lower-virulence organ-
isms, such as coagulase-negative staphylococci, can
present major problems for patients with orthopedic or
other implanted devices, or severely compromised
patients. The study definition was chosen in order to re-
flect the most common pathogens seen clinically at the
time and to include organisms for which there is high
concern for virulence and/or drug resistance [32,37].
Additionally, much greater microorganism diversity was
detected by PCR/ESI-TOF-MS, including unexpected
organisms with high virulence or outbreak potential
(e.g. Clostridium tetani, S. pyogenes). All surfaces, hands,
and PPE samples demonstrated large numbers of recov-
erable pathogens, but without clear trends related to
number of organisms by site. Based on these data, no
obvious target for increased infection control efforts was
seen in the study units. As this study was designed as a
pilot study with a small number of sites/samples tested,
there are clear limitations to the generalizability of the
results to an entire hospital microbiome. It is also diffi-
cult to draw conclusions about organisms such as
Shigella flexneri and Borrelia turicatae recovered from
the hospital environment in the absence of known clin-
ical cases during the study period. It is possible that
these represent misidentifications of related organisms,
as with hundreds of identified organisms, even 99% spe-
cificity would lead to several misidentifications. How-
ever, previous characterizations of this technology with
405 unique bacterial species have demonstrated accu-
rate characterization in 95% of instances, with the
remaining 5% unresolved species all accurate to the
genus level [15]. Other limitations of the use of PCR/
ESI-TOF-MS in this context include the possibility of
detection of nonviable organisms, cost, the semi-
quantitative nature of the data, and inability to recover
specific strains linked to a patient or outbreak isolate.
In this study, PCR/ESI-TOF-MS was not used to detect
specific strains of bacteria detected, though it can be
and has been used specifically for rapid genotyping of
A. baumannii [21], S. aureus [22] and Streptococcus
pneumoniae [38]. Thus, this technology may yet prove
useful in outbreak investigations using environmental
sampling, especially since it detected 4–5 fold higher
numbers of pathogens per site without adversely affect-
ing the ratio of clinically irrelevant microbes.
Interestingly, PCR/ESI-TOF-MS detected widespread
resistance elements throughout the hospital environ-
ment. In the case of mecA, most were associated with
CNS codetections rather than S. aureus. As mecA ele-
ments are widely distributed in CNS, this is not surpris-
ing [39]. VanA was not detected with enterococcus by
PCR/ESI-TOF-MS, but did have an association with the
presence of Lactobacillus spp. While this organism is
largely intrinsically resistant to vancomycin, previous
studies have demonstrated that this is not related to the
presence of vanA, which to our knowledge has not been
demonstrated in lactobacilli [40,41]. It is interesting that
one of the samples positive for vanA, but without
enterococci by PCR/ESI-TOF-MS, grew a susceptible
Enterococcus spp. on clinical culture. Furthermore, none
of the five samples positive for enterococci by TCM had
this organism codetected by PCR/ESI-TOF-MS, generat-
ing a question of whether there might have been specific
Enterococcus spp. detection problems, which have not
been previously described. Overall, there were no
attempts to resolve discordant results from TCM and
PCR/ESI-TOF-MS, given that essentially every sample
showed discordance, at least in greater number of pa-
thogens isolated by the latter method. The PCR/ESI-
TOF-MS technology does not screen for all possible re-
sistance genes, and as applied here only detects the re-
sistance element, without reporting whether it is
incorporated into the genome of an organism. If more
than one organism is present in the test sample along
with the resistance element, it was not clear with which
organism the element might be associated, if any. It is
possible that free-floating or promiscuous plasmids are
responsible for some of these detections, which also has
significance for infection transmission in recent litera-
ture [42]. Given the difficulty of performing plasmid
genetic analysis and whole genome sequencing of uncul-
turable organisms, it is likely that horizontal transmis-
sion and intergenus transfer of antimicrobial resistance
elements plays a larger role in healthcare-associated
transmission of gram-negative MDR pathogens than has
yet been described [43]. The ability of PCR/ESI-TOF-MS
to screen for a broad spectrum of genetic elements may
be a starting point for hypothesis development related to
horizontal transmission.
Conclusions
In summary, PCR/ESI-TOF-MS detected larger numbers
and a greater diversity of organisms from a higher pro-
portion of environmental surfaces in the hospital pilot
study, particularly pathogenic gram-negative organisms,
without adversely affecting the “signal-to-noise” ratio of
common skin contaminants detected. This may prove to
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be a useful technology for investigations of hospital out-
breaks. However, though PCR/ESI-TOF-MS has the cap-
acity to genotype organisms, its use in this screening
context did not provide for further information about
strain or antimicrobial resistance. Additionally, further
investigation is warranted in reference to the frequent
detection of resistance elements, particularly vanA, in
the absence of known host species for these resistance
elements. PCR/ESI-TOF-MS may be a useful adjunct
among infection control investigational tools for under-
standing transmission of endemic pathogens.
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